Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    The progesterone receptor Val660-->Leu polymorphism and breast cancer risk.

    De Vivo I, Hankinson SE, Colditz GA, Hunter DJ.

    Breast Cancer Res. 2004;6(6):R636-9. Epub 2004 Sep 22.

    PMID:
    15535845
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.

    Pooley KA, Healey CS, Smith PL, Pharoah PD, Thompson D, Tee L, West J, Jordan C, Easton DF, Ponder BA, Dunning AM.

    Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):675-82.

    PMID:
    16614108
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.

    Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC.

    J Natl Cancer Inst. 2005 Jan 5;97(1):51-9.

    PMID:
    15632380
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

    Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G.

    Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):439-43.

    PMID:
    12010857
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50.

    Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB.

    Cancer Res. 2000 May 1;60(9):2348-50.

    PMID:
    10811106
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.

    De Vivo I, Hankinson SE, Colditz GA, Hunter DJ.

    Cancer Res. 2003 Sep 1;63(17):5236-8.

    PMID:
    14500352
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.

    Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G; Kathleen Cuningham Consortium for Research in Familial Breast Cancer.

    Breast Cancer Res Treat. 2008 May;109(1):91-9. Epub 2007 Jun 26.

    PMID:
    17592773
    [PubMed - indexed for MEDLINE]
    8.

    Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.

    Liang J, Chen P, Hu Z, Zhou X, Chen L, Li M, Wang Y, Tang J, Wang H, Shen H.

    Carcinogenesis. 2008 Dec;29(12):2341-6. Epub 2008 Oct 8.

    PMID:
    18845558
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.

    Okobia MN, Bunker CH, Garte SJ, Zmuda JM, Ezeome ER, Anyanwu SN, Uche EE, Kuller LH, Ferrell RE, Taioli E.

    BMC Cancer. 2008 Nov 18;8:338.

    PMID:
    19017403
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer.

    Tamimi RM, Hankinson SE, Spiegelman D, Colditz GA, Hunter DJ.

    Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):989-96.

    PMID:
    15184255
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer.

    Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G.

    Carcinogenesis. 2001 May;22(5):717-21.

    PMID:
    11323389
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.

    Romano A, Lindsey PJ, Fischer DC, Delvoux B, Paulussen AD, Janssen RG, Kieback DG.

    Gynecol Oncol. 2006 May;101(2):287-95. Epub 2005 Dec 19.

    PMID:
    16360811
    [PubMed - indexed for MEDLINE]
    13.

    Genetic variation in the progesterone receptor gene and ovarian cancer risk.

    Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW.

    Am J Epidemiol. 2005 Mar 1;161(5):442-51.

    PMID:
    15718480
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Estrogen receptor genotypes and haplotypes associated with breast cancer risk.

    Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K.

    Cancer Res. 2004 Dec 15;64(24):8891-900.

    PMID:
    15604249
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.

    Huggins GS, Wong JY, Hankinson SE, De Vivo I.

    Cancer Res. 2006 Feb 1;66(3):1384-90.

    PMID:
    16452193
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

    Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO.

    BMC Med Genet. 2007 Dec 1;8:72.

    PMID:
    18053149
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

    J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

    PMID:
    15601642
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.

    Pearce CL, Wu AH, Gayther SA, Bale AE; Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK, Lissowska J, McGuire V, Modugno F, Moysich K, Ness RB, Ramus SJ, Risch HA, Sellers TA, Song H, Stram DO, Terry KL, Webb PM, Whiteman DC, Whittemore AS, Zheng W, Pharoah PD, Chenevix-Trench G, Pike MC, Schildkraut J, Berchuck A; Ovarian Cancer Association Consortium.

    Br J Cancer. 2008 Jan 29;98(2):282-8. Epub 2008 Jan 22.

    PMID:
    18219286
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

    Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.

    PMID:
    16807674
    [PubMed - indexed for MEDLINE]
    20.

    The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk.

    Cox DG, Hankinson SE, Hunter DJ.

    Pharmacogenet Genomics. 2005 Jul;15(7):447-50. Review.

    PMID:
    15970791
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk